改良富血小板血浆采集治疗间质性膀胱炎/膀胱疼痛综合征的标准化方案

Bladder (San Francisco, Calif.) Pub Date : 2025-03-14 eCollection Date: 2025-01-01 DOI:10.14440/bladder.2024.0052
Qiangping Zheng, Peng Zhang, Wei Guo, Jianzhong Zhang, Fan Zhang, Changran Ma, Yuanru Yang, Liyan Cui, Yuling Wu, Lei Zhang
{"title":"改良富血小板血浆采集治疗间质性膀胱炎/膀胱疼痛综合征的标准化方案","authors":"Qiangping Zheng, Peng Zhang, Wei Guo, Jianzhong Zhang, Fan Zhang, Changran Ma, Yuanru Yang, Liyan Cui, Yuling Wu, Lei Zhang","doi":"10.14440/bladder.2024.0052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and diagnostically challenging condition with limited treatment options and poor prognosis. Platelet-rich plasma (PRP) is a potential treatment for IC/BPS. Nonetheless, conventional preparation methods are inefficient, necessitating an improved approach.</p><p><strong>Objective: </strong>To design an effective and safe protocol for collecting PRP for intravesical injections for the treatment of IC/BPS.</p><p><strong>Methods: </strong>We evaluated the feasibility of the PRP collection protocol from 17 patients. After venipuncture, blood was processed using a blood cell separator containing saline and anticoagulant. One milliliter of PRP was retained for platelet concentration analysis. Each patient received six PRP injections, and their clinical data were taken before and after the procedure to assess efficacy.</p><p><strong>Results: </strong>The mean platelet enrichment coefficient was 5.11 ± 1.27, the mean flow rate was 33.19 ± 6.77 mL/min, the mean collection volume was 125.13 ± 17.49 mL, and the mean collection time was 73.69 ± 10.17 min. Eleven patients required deep venous catheterization because superficial venipuncture failed. No adverse reactions were observed during collection, and all other blood components were retained. Three patients completed six injections, four received five injections, three received four injections, one received three injections, two received two injections, and four received one injection. After treatment, 12 of 17 patients showed symptom improvement on the Global Response Assessment scale (≥5), and all demonstrated statistically significant improvements in terms of O'Leary-Sant and Visual Analog Scale scores against baseline. One patient, however, developed gross hematuria after the fourth injection.</p><p><strong>Conclusions: </strong>The proposed PRP collection protocol is relatively safe and effective. Preliminary data suggest that intravesical PRP injection is a promising treatment for IC/BPS.</p>","PeriodicalId":72421,"journal":{"name":"Bladder (San Francisco, Calif.)","volume":"12 1","pages":"e21200034"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308113/pdf/","citationCount":"0","resultStr":"{\"title\":\"A standardized protocol for modified platelet-rich plasma collection for the treatment of interstitial cystitis/bladder pain syndrome.\",\"authors\":\"Qiangping Zheng, Peng Zhang, Wei Guo, Jianzhong Zhang, Fan Zhang, Changran Ma, Yuanru Yang, Liyan Cui, Yuling Wu, Lei Zhang\",\"doi\":\"10.14440/bladder.2024.0052\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and diagnostically challenging condition with limited treatment options and poor prognosis. Platelet-rich plasma (PRP) is a potential treatment for IC/BPS. Nonetheless, conventional preparation methods are inefficient, necessitating an improved approach.</p><p><strong>Objective: </strong>To design an effective and safe protocol for collecting PRP for intravesical injections for the treatment of IC/BPS.</p><p><strong>Methods: </strong>We evaluated the feasibility of the PRP collection protocol from 17 patients. After venipuncture, blood was processed using a blood cell separator containing saline and anticoagulant. One milliliter of PRP was retained for platelet concentration analysis. Each patient received six PRP injections, and their clinical data were taken before and after the procedure to assess efficacy.</p><p><strong>Results: </strong>The mean platelet enrichment coefficient was 5.11 ± 1.27, the mean flow rate was 33.19 ± 6.77 mL/min, the mean collection volume was 125.13 ± 17.49 mL, and the mean collection time was 73.69 ± 10.17 min. Eleven patients required deep venous catheterization because superficial venipuncture failed. No adverse reactions were observed during collection, and all other blood components were retained. Three patients completed six injections, four received five injections, three received four injections, one received three injections, two received two injections, and four received one injection. After treatment, 12 of 17 patients showed symptom improvement on the Global Response Assessment scale (≥5), and all demonstrated statistically significant improvements in terms of O'Leary-Sant and Visual Analog Scale scores against baseline. One patient, however, developed gross hematuria after the fourth injection.</p><p><strong>Conclusions: </strong>The proposed PRP collection protocol is relatively safe and effective. Preliminary data suggest that intravesical PRP injection is a promising treatment for IC/BPS.</p>\",\"PeriodicalId\":72421,\"journal\":{\"name\":\"Bladder (San Francisco, Calif.)\",\"volume\":\"12 1\",\"pages\":\"e21200034\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12308113/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bladder (San Francisco, Calif.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14440/bladder.2024.0052\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bladder (San Francisco, Calif.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14440/bladder.2024.0052","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:间质性膀胱炎/膀胱疼痛综合征(IC/BPS)是一种慢性且具有诊断挑战性的疾病,治疗方案有限且预后差。富血小板血浆(PRP)是一种治疗IC/BPS的潜在方法。然而,传统的制备方法是低效的,需要改进的方法。目的:设计一种有效、安全的膀胱内注射PRP治疗IC/BPS的方案。方法:对17例患者的PRP采集方案进行可行性评估。静脉穿刺后,血液用含有生理盐水和抗凝剂的血细胞分离器处理。保留1毫升PRP用于血小板浓度分析。每位患者接受6次PRP注射,并在术前和术后采集临床资料以评估疗效。结果:平均血小板富集系数为5.11±1.27,平均流速为33.19±6.77 mL/min,平均采集量为125.13±17.49 mL,平均采集时间为73.69±10.17 min。11例患者因浅表静脉穿刺失败需行深静脉置管。采集过程中未见不良反应,其他血液成分全部保留。3名患者注射了6针,4名患者注射了5针,3名患者注射了4针,1名患者注射了3针,2名患者注射了2针,4名患者注射了1针。治疗后,17例患者中有12例在全球反应评估量表上表现出症状改善(≥5),并且在O'Leary-Sant和视觉模拟量表评分方面均表现出与基线相比具有统计学意义的改善。然而,一名患者在第四次注射后出现肉眼血尿。结论:提出的PRP采集方案相对安全有效。初步数据表明,膀胱内PRP注射是一种有希望的治疗IC/BPS的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

A standardized protocol for modified platelet-rich plasma collection for the treatment of interstitial cystitis/bladder pain syndrome.

A standardized protocol for modified platelet-rich plasma collection for the treatment of interstitial cystitis/bladder pain syndrome.

A standardized protocol for modified platelet-rich plasma collection for the treatment of interstitial cystitis/bladder pain syndrome.

Background: Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and diagnostically challenging condition with limited treatment options and poor prognosis. Platelet-rich plasma (PRP) is a potential treatment for IC/BPS. Nonetheless, conventional preparation methods are inefficient, necessitating an improved approach.

Objective: To design an effective and safe protocol for collecting PRP for intravesical injections for the treatment of IC/BPS.

Methods: We evaluated the feasibility of the PRP collection protocol from 17 patients. After venipuncture, blood was processed using a blood cell separator containing saline and anticoagulant. One milliliter of PRP was retained for platelet concentration analysis. Each patient received six PRP injections, and their clinical data were taken before and after the procedure to assess efficacy.

Results: The mean platelet enrichment coefficient was 5.11 ± 1.27, the mean flow rate was 33.19 ± 6.77 mL/min, the mean collection volume was 125.13 ± 17.49 mL, and the mean collection time was 73.69 ± 10.17 min. Eleven patients required deep venous catheterization because superficial venipuncture failed. No adverse reactions were observed during collection, and all other blood components were retained. Three patients completed six injections, four received five injections, three received four injections, one received three injections, two received two injections, and four received one injection. After treatment, 12 of 17 patients showed symptom improvement on the Global Response Assessment scale (≥5), and all demonstrated statistically significant improvements in terms of O'Leary-Sant and Visual Analog Scale scores against baseline. One patient, however, developed gross hematuria after the fourth injection.

Conclusions: The proposed PRP collection protocol is relatively safe and effective. Preliminary data suggest that intravesical PRP injection is a promising treatment for IC/BPS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信